Will Lantern Bioworks's cavity-curing bioengineered S. mutans (Lumina) turn out to have horrible downsides by 2029?
One-OffHealth & MedicineWissenschaft2JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 94.1%
Prognostiker
36
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 4 Stunden
Veraltet8. Okt. 23, 09:05 UTC16. Dez. 28, 07:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2028?
Manifold MarketsWill Lantern Bioworks be sued over harm caused by their Lumina treatment by the end of 2028?
Manifold MarketsWill Lantern Bioworks be acquired by the end of 2028?
Manifold MarketsWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiWhich countries will report an Ebola case in 2026?
KalshiWhich countries will have an Ebola case in 2026?
PolymarketRegeln
Lantern Bioworks is working on genetically modified Streptococcus mutans bacteria (Lumina Probiotic) that produce ethanol instead of lactic acid and that excrete the antibiotic mutacin 1140.
- In theory, they can outcompete natural S. mutans in your mouth and prevent you from getting any cavities ever again.
- Is there some horrible downside to this treatment? I plan to check at the beginning of 2029 whether some horrible downside has been discovered.
- Market resolves to my best judgment at that point.
- If the treatment doesn't work but has no ill effects, resolves NO.
- If the treatment doesn't work but people change their behavior on the assumption that it does (e.g. living on a candy diet post-treatment) and their changed behavior results in horrible dental consequences, resolves NO.
Offene Märkte
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 18.288,2 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 5178,9 €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 weitere Ergebnisse
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Gesamtvolumen
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Gesamtvolumen
- 916.002,6 €
- 24h-Volumen
- 1515,1 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 weitere Ergebnisse
- Gesamtvolumen
- 863.640,2 €
- 24h-Volumen
- 1039 €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will Lantern Bioworks's cavity-curing bioengineered S. mutans (Lumina) turn out to have horrible downsides by 2029??
- Manifold Markets bewertet No mit 94% (Stand: 8. September 2026).
- Wann wird Will Lantern Bioworks's cavity-curing bioengineered S. mutans (Lumina) turn out to have horrible downsides by 2029? entschieden?
- Will Lantern Bioworks's cavity-curing bioengineered S. mutans (Lumina) turn out to have horrible downsides by 2029? soll am 16. Dezember 2028 entschieden werden.
- Wie wird Will Lantern Bioworks's cavity-curing bioengineered S. mutans (Lumina) turn out to have horrible downsides by 2029? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: Lantern Bioworks is working on genetically modified Streptococcus mutans bacteria (Lumina Probiotic) that produce ethanol instead of lactic acid and that excrete the antibiotic mutacin 1140.